Beyond Dawlish

The pharmaceutical industry is evolving rapidly, and one of the most significant trends shaping its growth is third-party manufacturing. This model allows pharmaceutical companies to outsource the production of medicines and healthcare products to specialized contract manufacturers. It has emerged as a cost-effective and scalable solution, enabling companies to expand their product offerings without investing heavily in infrastructure and production facilities